Heart Disease News and Research

Latest Heart Disease News and Research

Robert Wood Johnson Foundation announces winners of 2012 Community Health Leaders Award

The Robert Wood Johnson Foundation is proud to announce today the recipients of its 2012 Community Health Leaders Award, honoring 10 individuals who have surmounted significant challenges to help improve health and health care in their communities.

17 Oct 2012

Study finds overall decline in cholesterol levels among U.S. adults

An analysis of nationally-representative data indicates that between 1988 and 2010 there has been a trend of declining average levels of total cholesterol, non-high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol for U.S. adults overall, according to a study in the October 17 issue of JAMA.

17 Oct 2012

Saint Mary's, Mercy Health and VAI sign agreements to expand biorepository

Van Andel Institute (VAI) and two West Michigan hospitals within the national Trinity Health system and members of Mercy Health - Saint Mary's Health Care and Mercy Health Partners - have signed agreements paving the way for the expansion of a world-class biorepository utilizing the infrastructure of the VAI Program for Biospecimen Science.

17 Oct 2012

UK HealthCare's Gill Heart Institute cardiologists perform TAVR procedures

Interventional cardiologists at UK HealthCare's Gill Heart Institute have successfully performed the facility's first two transcatheter aortic valve replacements.

17 Oct 2012

UMass professor receives $1 million LRI grant for lupus research

The Lupus Research Institute (LRI) has named University of Massachusetts Medical School Professor of Medicine Ann Marshak-Rothstein, MD, one of two recipients of the first LRI Distinguished Innovator Awards.

17 Oct 2012

USPTO issues patent to Positron’s solid state sensors

Positron Corporation announced today that the United States Patent and Trademark Office (USPTO) has awarded the Company a patent (U.S. No. 8,269,181) for its original semiconductor detector used in high precision measuring of coordinates and detection of ionization particles.

17 Oct 2012

Resverlogix commences RVX-208 Phase 2 trial in pre-diabetes mellitus

Resverlogix Corp. today announced that it has initiated an exploratory Phase 2 clinical trial in patients with pre-diabetes mellitus to examine the effects of RVX-208 and ApoA-I production on glucose metabolism.

17 Oct 2012

Multi-system exposure related illness (MERI)

The Global Health Network has released a new paper titled “Common Toxins in our Homes, Schools and Workplaces.” According to an Environmental Protection Agency (EPA) spokesman, indoor air pollution causes 50% of illnesses globally. This statistic should catch the attention of every physician, every lawmaker and every layperson reading this paper. That’s more than all the cancers and all the heart disease combined. It is time we started to pay more attention to the indoor air we breathe. It is staggering to comprehend the enormous impact on our global society as literally millions of individuals and families are harmed by contaminants inside our homes, schools and workplaces.

16 Oct 2012

Kids encouraged to Stand Up for their health and be active

Children and adolescents are accumulating up to eight hours of sitting on a daily basis, research to be presented at Australia’s paramount sports medicine, sports science, sports injury prevention and physical activity promotion conference, be active2012 will show (October 31- November 3, Sydney).

16 Oct 2012

Early pollution exposure has long-lasting respiratory effects

Exposure to traffic-related pollution during the first year of life continues to affect lung function at age 8 years, show the results of a Swedish study.

16 Oct 2012

Rehabilitation program combats occupational skin disease

Results from a German study suggest that a 6–10 week rehabilitation program set up to help people overcome severe occupational skin disease continues to have significant benefits for participants 1 year after discharge.

16 Oct 2012

Sustained attention deficits in bipolar patients, relatives

Patients with bipolar disorder and their first-degree relatives exhibit deficits in sustained attention, study results show.

16 Oct 2012

Sitting on a cardiac timebomb

People who sit for long periods of time have an increased risk for diabetes, heart disease, and mortality, even if they undertake the recommended amount of exercise each day, say researchers.

16 Oct 2012

CKD may thicken carotid arteries, raise CVD risk in children

Findings from a US study show that carotid intima-media thickness is significantly higher among children with mild-to-moderate chronic kidney disease than in children without the kidney condition.

16 Oct 2012

Experts blaze TRAIL for pulmonary arterial hypertension therapy

Researchers have shown that the cell signaling molecule tumor necrosis factor-related apoptosis-inducing ligand may be a potential therapeutic target for pulmonary arterial hypertension.

16 Oct 2012

IMS develops review on weight gain at the menopause

To mark World Menopause Day (18th October) the International Menopause Society has developed a state-of-the-science review on weight gain at the menopause. This report is published in the peer-reviewed journal, Climacteric.

16 Oct 2012

Major academic medical centers, teaching hospitals to form Chicago Adult Congenital Heart Network

Seven major academic medical centers and teaching hospitals in the Chicago area have joined together to form the Chicago Adult Congenital Heart Network (CATCH), which is the first patient-centered, inter-institutional network in Chicago established to ensure all adults with congenital heart disease in the area receive appropriate follow-up care.

16 Oct 2012

Intensive treatment with high doses of statin drugs shows promise for dyslipidemia

A comprehensive new review on how to treat high cholesterol and other blood lipid problems suggests that intensive treatment with high doses of statin drugs is usually the best approach.

16 Oct 2012

First Edition: October 16, 2012

Today's early morning highlights from the major news organizations, including reports about a study regarding the possible impact of premium support on Medicare premiums.

16 Oct 2012

LRRK2 inhibitors may provide neuroprotection for patients with Parkinson's

For decades, patients with Parkinson's disease (PD) have had the same experience. Their hands start to shake uncontrollably, their limbs become rigid and they lose their balance. Years before those movement problems set in, many begin struggling with fainting, incontinence, sexual dysfunction, anxiety and depression. Many patients are still treated with a 42-year-old drug called L-DOPA, which temporarily staves off symptoms but can itself cause heart arrhythmias, stomach bleeding and hallucinations.

16 Oct 2012